GlaxoSmithKline plc (ADR) (GSK)
$40.52
0.06 (+0.15%)
| CAPS Rating |
|
|---|---|
| Open | $39.84 |
| Previous Close | $40.46 |
| Daily Range | $39.82 - $40.52 |
| 52-Week Range | $27.15 - $42.18 |
| Market Cap | $114.7B |
| P/E Ratio | 10.45 |
| Dividend (Yield) | 1.85 (4.60%) |
| Volume | 1,429,938 |
| Average Daily Volume | 1,567,000 |
How do you think GSK will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GSK Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GSK News and Commentary
- The Downside of Dollar-Cost Averaging – The Motley Fool
- Slow Down There, Merck – The Motley Fool
- Let This Winning Combination Make You Wealthy – The Motley Fool
- XNPT is on the move – Blog at The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- 5-Star Stocks Worth a Look – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Small Savings Add Up to a Big Payoff – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- Of One-Time Gains and Pipelines – The Motley Fool
- World's Scariest Stocks: Pfizer – The Motley Fool
- The Next 3 Dividend Dynamos – The Motley Fool
- Saved by Emerging Markets. Sort Of. – The Motley Fool
- Don't Miss This Cheap Stock – The Motley Fool
- Not 50% Growth, but We'll Take It – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- Companies You Should Buy Right Now – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool


RSS Headlines
Fool UK